NCT02993042

Brief Summary

Robot-assisted gait training can improve gait ability of patients with Parkinson's disease by repeating a normal gait pattern with high intensity. This study is a feasibility study to investigate whether robot-assisted gait training can be applied to improve walking autonomy in patients with Parkinson 's disease.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12

participants targeted

Target at below P25 for not_applicable parkinson-disease

Timeline
Completed

Started Dec 2016

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2016

Completed
5 days until next milestone

First Submitted

Initial submission to the registry

December 6, 2016

Completed
8 days until next milestone

First Posted

Study publicly available on registry

December 14, 2016

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2018

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2018

Completed
Last Updated

March 9, 2018

Status Verified

March 1, 2018

Enrollment Period

1.1 years

First QC Date

December 6, 2016

Last Update Submit

March 8, 2018

Conditions

Keywords

RehabilitationRobot-assisted gait training

Outcome Measures

Primary Outcomes (2)

  • Percentage of dual-task interference: cognitive

    (Cognitive dual-task performance - Single-task performance) / Single-task performance during 10 meter walk test

    at 4 weeks

  • Percentage of dual-task interference: physical

    (Physical dual-task performance - Single-task performance) / Single-task performance during 10 meter walk test

    at 4 weeks

Secondary Outcomes (9)

  • 10 meter walk test (sec): single, cognitive dual-task, physical dual-task

    baseline, at 4 weeks, at 8 weeks

  • Berg balance scale

    baseline, at 4 weeks, at 8 weeks

  • Korean version of the Falls Efficacy Scale-International

    baseline, at 4 weeks, at 8 weeks

  • Step length

    baseline, at 4 weeks, at 8 weeks

  • Step width

    baseline, at 4 weeks, at 8 weeks

  • +4 more secondary outcomes

Study Arms (1)

Robot-assisted gait training

EXPERIMENTAL

Robot-assisted gait training using an exoskeletal robot (Walkbot\_S; P\&S Mechanics Co. Ltd., Seoul, Korea)

Device: Robot-assisted gait training

Interventions

Patients should use their belts (Harness) to support their weight when walking in equipment. In the first training session, the patient focuses on fitting and adapting the equipment and helps the patient learn. To minimize skin damage, the patient can wear a protector. The initial walking speed starts at 1.5km / h (0.42m / s) and can be increased gradually to 3.0km / h (0.83m / s) by increasing to 0.2km / h (0.06m / s) per session. The therapist provides appropriate visual and auditory instructions to allow the patient to participate as fully as possible in the walking cycle provided by the walking robot. The treatment time per session is 30 minutes except for the time of wearing and releasing.

Robot-assisted gait training

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Clinically confirmed patients with idiopathic Parkinson's disease
  • Hoehn \& Yahr stage 2.5 or 3 patients
  • Patients with a Mini-Mental Status Examination (MMSE) score of 24 or higher

You may not qualify if:

  • Patients with severe dyskinesia or on-off fluctuations due to medication
  • Patients who need to change drugs during the study period
  • Patients with sensory abnormalities of the lower limb
  • Patients with vestibular disease or paroxismal vertigo
  • Patients with other neurological or orthopedic disease involving legs, or severe cardiovascular diseases

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Seoul National University Hospital

Seoul, 03080, South Korea

Location

MeSH Terms

Conditions

Parkinson DiseaseGait Disorders, Neurologic

Condition Hierarchy (Ancestors)

Parkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersSynucleinopathiesNeurodegenerative DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Assistant Professor

Study Record Dates

First Submitted

December 6, 2016

First Posted

December 14, 2016

Study Start

December 1, 2016

Primary Completion

January 1, 2018

Study Completion

February 1, 2018

Last Updated

March 9, 2018

Record last verified: 2018-03

Locations